In Liberia, it is estimated that at least 46% of the population accesses antimalarials through the private sector. Quality-assured ACTs, however, are generally more expensive than older antimalarials; therefore, the majority of these outlets still stock chloroquine and other monotherapies. According to the 2010–15 national malaria strategic plan, MOHSW is committed to increasing access to prompt and effective treatment.
President’s Malaria Initiative: Private Sector Distribution of Artemisinin-Based Combination Therapies in Liberia
By Amber Pitts on April 13, 2012 in Assessment, Distribution, Health Areas, Liberia, Malaria, Mode of Implementation, Supply Chain Management, Technical Report, Where We Work